Department of Biochemistry/ Stem Cell Research, National Institute of Nutrition (ICMR, Department of Health Research), Hyderabad, India.
Tissue Cell. 2011 Aug;43(4):266-70. doi: 10.1016/j.tice.2011.03.007. Epub 2011 May 7.
The promise(s) of using Fetal Calf Serum (FCS) as a supplement for the maintenance of cell cultures has been well documented. However, FCS forms the xenogenic source for any human derived cells/organ and limits its application. Recently, the usage of human umbilical cord blood serum (hUCBS) for maintenance of mesenchymal cells has been supportive. In the present study we investigated the effects of hUCBS and FCS on the proliferation (viability, proliferative) and its differentiation potential (DTZ staining, immunofluroscence) to generate islet like cellular aggregates (ICAs) using the human derived Panc-1 cell lines. A comparative analysis of hUCBS and FCS for each parameter demonstrated that hUCBS supplemented media was better for proliferation and differentiation of the Panc-1 cells. The ICAs obtained from hUCBS primed cultures showed a higher yield, increased islet size, and showed an increase for insulin staining compared to FCS. We suggest that hUCBS can be explored as an alternate serum supplement for FCS, making it more feasible in cell systems of human derived origin and can also find its application for the human transplantation programmes.
使用胎牛血清(FCS)作为细胞培养的补充物的承诺已有充分记录。然而,FCS 是任何源自人类的细胞/器官的异种来源,并限制了其应用。最近,使用人脐带血血清(hUCBS)来维持间充质细胞已经得到了支持。在本研究中,我们研究了 hUCBS 和 FCS 对增殖(活力、增殖)及其分化潜能(DTZ 染色、免疫荧光)的影响,以使用人源 Panc-1 细胞系生成胰岛样细胞聚集物(ICAs)。对 hUCBS 和 FCS 每个参数的比较分析表明,hUCBS 补充培养基更有利于 Panc-1 细胞的增殖和分化。与 FCS 相比,来自 hUCBS 启动培养物的 ICA 显示出更高的产量、更大的胰岛大小,并显示出胰岛素染色的增加。我们建议可以探索 hUCBS 作为 FCS 的替代血清补充物,使其更适用于源自人类的细胞系统,也可以为人类移植计划找到应用。